ACVR1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.596400E-01
Normal-vs-Stage2
7.164000E-01
Normal-vs-Stage3
4.822400E-01
Normal-vs-Stage4
4.405800E-01
Stage1-vs-Stage2
5.499600E-01
Stage1-vs-Stage3
3.483400E-01
Stage1-vs-Stage4
2.411000E-01
Stage2-vs-Stage3
1.432590E-01
Stage2-vs-Stage4
2.326200E-01
Stage3-vs-Stage4
1.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.685000E-01
Normal-vs-AfricanAmerican
8.582200E-01
Normal-vs-Asian
7.558200E-01
Caucasian-vs-AfricanAmerican
8.655400E-01
Caucasian-vs-Asian
7.748800E-01
AfricanAmerican-vs-Asian
7.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.024400E-01
Normal-vs-Female
8.159000E-01
Male-vs-Female
6.615400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.554000E-01
Normal-vs-Age(41-60Yrs)
6.197800E-01
Normal-vs-Age(61-80Yrs)
7.833800E-01
Normal-vs-Age(81-100Yrs)
8.678000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.797600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.460400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.004400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.927800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.000200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.800400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.955600E-01
Normal-vs-Daily Drinker
9.544800E-01
Normal-vs-Weekly Drinker
8.971000E-01
Normal-vs-Occasional Drinker
5.480000E-01
Normal-vs-Social Drinker
6.608400E-01
Non Drinker-vs-Daily Drinker
4.766200E-01
Non Drinker-vs-Weekly Drinker
4.578800E-01
Non Drinker-vs-Occasional Drinker
3.536200E-01
Non Drinker-vs-Social Drinker
8.348600E-01
Daily Drinker-vs-Weekly Drinker
8.567600E-01
Daily Drinker-vs-Occasional Drinker
1.414610E-01
Daily Drinker-vs-Social Drinker
3.569600E-01
Weekly Drinker-vs-Occasional Drinker
1.912010E-01
Weekly Drinker-vs-Social Drinker
3.656200E-01
Occasional Drinker-vs-Social Drinker
4.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.443700E-02
Normal-vs-Grade 2
1.322330E-02
Normal-vs-Grade 3
9.396600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.901400E-01
Grade 1-vs-Grade 3
8.653200E-01
Grade 1-vs-Grade 4
5.443700E-02
Grade 2-vs-Grade 3
9.371200E-01
Grade 2-vs-Grade 4
1.322330E-02
Grade 3-vs-Grade 4
9.396600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.647600E-01
Normal-vs-NonDiabetic
7.409800E-01
Diabetic-vs-NonDiabetic
3.817600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.092400E-01
Normal-vs-NoPancreatitis
7.970800E-01
Pancreatitis-vs-NoPancreatitis
2.360400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.504400E-01
Normal-vs-N1
6.460600E-01
N0-vs-N1
1.853590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.118800E-01
Normal-vs-TP53-NonMutant
5.161000E-01
TP53-Mutant-vs-TP53-NonMutant
4.255200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
